Arena Pharmaceuticals, Inc. (ARNA): This Could Be A Major Blockbuster
It's been a long road, but Eisai and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)' obesity drug Belviq can finally launch in 30 days.
Posts Tagged ‘Johnson & Johnson (JNJ)’
Prestige Brands Holdings, Inc. (PBH), Johnson & Johnson (JNJ): The Quest for a Hidden Bargain, Not Over Yet!
Prestige Brands Holdings, Inc. (NYSE:PBH) produces a wide variety of over-the-counter medications and household cleaning products, a lot of which are very well-known names.
Alcoa Inc (AA), Intel Corporation (INTC): The Dow (.DJI)’s Five Most Hated Stocks
Since the Dow Jones Industrial Average (Dow Jones Indices:.DJI) hit an all-time record high on Friday on the heels of a better-than-expected jobs report, there's no shortage of...
Will Dendreon Corporation (DNDN) Ever Make Money?
On Thursday, Dendreon Corporation (NASDAQ:DNDN) will release its latest quarterly results.
How Johnson & Johnson (JNJ) Risks Your Money
Investing genius Charlie Munger advises us to "[n]ever, ever think about something else when you should be thinking about the power of incentives." But that's just what Johnson...
Bank of America Corp (BAC) Is Booming: Here’s What You Should Know
In the aftermath of last week's big record run for the stock market, it's no surprise to see the bull-market rally take a brief pause.
Bristol Myers Squibb Co. (NBMY), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Apple Inc. (AAPL), Johnson & Johnson (JNJ), The Procter & Gamble Company (PG): Why Value Stocks Are Beating Growth Stocks
With the S&P 500 having hit new all-time record highs on Friday, it's a good time to take a look back and see where the index's most recent gains have come from.
McDonald’s Corporation (MCD), Cisco Systems, Inc. (CSCO), Johnson & Johnson (JNJ): Should You Sell in May and Go Away?
As the calendar turns toward the second quarter of the year, it’s again time to revisit the popular investing adage, "Sell in May and go away." As the theory stipulates, investors...
General Electric Company (GE), United Technologies Corporation (UTX), Johnson & Johnson (JNJ): Three Value Stocks Worthy of Your Portfolio
Outperforming the S&P 500 is no easy feat, as the vast majority of portfolios fail to meet that the goal annually.
Google Inc (GOOG), Baidu.com, Inc. (BIDU), National-Oilwell Varco, Inc. (NOV): Three Buy Now Stocks From the “World’s Greatest Retirement Portfolio”
A full 23 months ago, I identified 10 companies that I would be putting $40,000 of my own retirement money behind.
Johnson & Johnson (JNJ), And Why The Procter & Gamble Company (PG) Is A Buy
Blue chip stocks are great companies to add to your portfolio. They have a long history of strong growth and have strong, reputable brands.
Is PepsiCo, Inc. (PEP) Worth Buying?
PepsiCo, Inc. (NYSE:PEP) is a renowned food and beverage company with a diversified product portfolio that includes a long list of acceptable brands.
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Microsoft Corporation (MSFT): Ready For This?
I believe Microsoft Corporation (NASDAQ:MSFT) is getting closer to finally being recognized by Mr.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Take Two Dividend Stocks and Call Me in the Morning
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Apple Inc. (AAPL) iBond-ies Must Watch For This
Yesterday, Apple Inc. (NASDAQ:AAPL) set records with its $17 billion offering of bonds, making it the largest corporate bond offering ever.
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
Merck & Co., Inc. (MRK): Post-Earnings Performance Questions
Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday.
Abbott Laboratories (ABT), AbbVie Inc (ABBV) & More: Did You Know That This Stock Is Half What It Had Been?
Abbott Laboratories (NYSE:ABT) stock hit a high in October of last year of 72.47, but when the new year hit, the company split in two, spinning its drug assets into AbbVie Inc...
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY) And Why Diabetes Isn’t Good for Health, But It Can Be for Your Portfolio
When I was six years old, something happened to me that I have never forgotten and will probably always live with.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Covidien plc (COV), Johnson & Johnson (JNJ), General Electric Company (GE): Has This Stock Priced in the Near Term Risk?
One of the peculiar aspects of the market move upwards in 2013 is that the defensives have led the way while the traditionally more economically sensitive areas like technology...
Abbott Laboratories (ABT), Boston Scientific Corporation (BSX), Johnson & Johnson (JNJ): Blame Obamacare for the Medical-Device Sales Slump?
Has anyone noticed a common theme among the first-quarter results for many of the big medical-device companies? In case you missed earnings announcements from Abbott Laboratories...
Stryker Corporation (SYK), Johnson & Johnson (JNJ): Earnings Pain Intensifies in the Medical-Device Industry
Earnings season hasn't been kind to medical-device makers so far.
The Procter & Gamble Company (PG), And How to Assess A Declining Level of Dividend Increases
The Procter & Gamble Company (NYSE:PG) is one of the most popular dividend stocks in the world with an impressive payout history that includes 122 years of uninterrupted dividends...
Caterpillar Inc. (CAT), Alcoa Inc. (AA), Johnson & Johnson (JNJ): The Weak Economy Threatens the Bull Market
This morning's news that the U.S.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Johnson & Johnson (JNJ), The Procter & Gamble Company (PG): How To Invest Despite Long-Tail Risk Part II
Investors have been shifting out of investments that protect against rare, but catastrophic risks. With the market near all time highs, those risks are still very real.
Abbott Laboratories (ABT): Yawn All The Way to Retirement With It
After spinning off its pharmaceutical business -- and most of its dividend, essentially -- you may think Abbott Laboratories (NYSE:ABT) is relegated to a boring medical-device...
Merck & Co., Inc. (MRK): One Potential Roadblock For A Stock Runup
If you own Merck & Co., Inc. (NYSE:MRK) stock, you likely enjoyed the past couple of months.
Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?
Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they're more like $12 billion or more a dozen, but you get the point.
Google Inc (GOOG), Apple Inc. (AAPL) & More: Despite Positive News, ‘The World’s Greatest Retirement Portfolio’ Isn’t Getting Much Love
Two years ago, I picked 10 stocks that I'd be putting $40,000 of my own money behind and attempting to hold for at least three years.
Johnson & Johnson (JNJ), PepsiCo, Inc. (PEP): Go Beyond Large-Cap ETFs For Dividends
Venerable dividend-payers such as Johnson & Johnson (NYSE:JNJ), PepsiCo, Inc.
GameStop Corp. (GME), Pfizer Inc. (PFE) and More: iShares Bolsters Factor ETF Lineup With 5 New Funds
BlackRock, Inc. (NYSE:BLK) iShares unit, the world's largest ETF issuer, added to its lineup of factor-driven ETFs today with the debut of five new funds.
PepsiCo, Inc. (PEP), Kraft Foods Group Inc (KRFT) and The Mystery of Groceries: Do All Brands Come From the Same Place?
When you visit the grocery store with those choices on your mind, you may think you're choosing among different brands, but in fact, you're just choosing between various flavors...
Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ), and Investing in Potential Blockbusters
A popular drug that crosses a benchmark sale of $1 billion for the manufacturer is called a blockbuster drug.
Should You Buy Abbott Laboratories (ABT)?
Abbott Laboratories (NYSE:ABT) reported its quarterly earnings on April 17.
Johnson & Johnson (JNJ): Will Dividend Growth for This Dividend King Start Slowing?
Johnson & Johnson (NYSE:JNJ) has been considered a dividend growth star for a number of years now.
Merck & Co., Inc. (MRK): It Is Not Worth It
Big pharma companies are massive, complicated beasts.
Hedge Fund News: Warren Buffett, Steve Cohen, Sprint Nextel Corporation (S)
Editor's Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc.
Bank of America Corp (BAC): Why It Has Sunk the Dow
Earnings season has the power to lift companies and instill optimism in investors -- but it also has the ability to take down stocks with the force of a hurricane.
Abbott Laboratories (ABT): Three Things You Need to Know in the Wake of Its Earnings
2013 has been a big year for Abbott Laboratories (NYSE:ABT).
Microsoft Corporation (MSFT), Johnson & Johnson (JNJ) Among The 3 Highest-Yielding Stocks In this Fund
Donald Yacktman, the President and Co-Chief Investment Officer of Yacktman Asset Management, is managing around $17 billion in total assets.
Johnson & Johnson (JNJ): Three Things You Need to Watch
Earnings season's in full throttle now, and Johnson & Johnson (NYSE:JNJ) stepped up and released its quarterly data Tuesday.
Johnson & Johnson (JNJ): This Stock Is Trouncing the Dow (.DJI)
The Dow Jones Industrial Average is down after Bank of America Corp (NYSE:BAC) and Intel Corporation (NASDAQ:INTC) both reported weaker-than-expected earnings, pulling their ...
Microsoft Corporation (MSFT), Johnson & Johnson (JNJ) Among Five Leading Companies in Human Rights
Like most investors, you probably aim for the best possible return when picking potential investments.
The Coca-Cola Company (KO), Johnson & Johnson (JNJ): Dow Jones Industrial Average (.DJI) Gets Fizzy With It
After its worst day of the year yesterday, the Dow Jones Industrial Average (INDEXDJX:.DJI) bounced back today as investors saw buying opportunities and responded to a strong ...
Johnson & Johnson (JNJ): Here’s Why It’s Boosting the Dow (.DJI)
Something that sets us Foolish investors apart is that we like to be in control of our own finances.
